IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

Refractory Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

IM19 CAR-T cells

IM19 CAR-T cells by intravenous infusion.

Trial Locations (1)

RECRUITING

Peking Universitiy Third Hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER